Journal Article

Association of Preoperative and Postoperative Plasma Syndecan-1 and Colorectal Cancer Outcome

MORI, RYUTARO, HAYASHI, HIROKATSU, FUTAMURA, MANABU, SATO, YUTA, YASUFUKU, ITARU, FUKADA, MASAHIRO, KUNO, MASASHI, TOMITA, HIROYUKI, TANAKA, YOSHIHIRO, ASAI, RYUICHI, TANAKA, HIDENORI, YOKOI, RYOMA, TOKUMARU, YOSHIHISA, MATSUHASHI, NOBUHISA, TAJIMA, JESSE YU, TSUCHIYA, HIROSHI, OKUMURA, NAOKI

2024

Overview

A three-dimensional network constructed using glycocalyx (GCX) extends throughout the cancer cell nest in human colorectal cancer (CRC). GCX was found to be closely related to cancer. We examined the prognostic correlation and potential of syndecan-1 (SDC1), a representative proteoglycan of GCX, as a biomarker. We analyzed SDC1 in the transcriptomic profiles of a major publicly available CRC cohort from The Cancer Genome Atlas (TCGA) using a computational algorithm. We investigated serum SDC1 levels preoperatively and on postoperative day seven in 48 patients with stage I-III CRC who underwent surgery during July-December 2019 at Gifu University Hospital. For TCGA, no significant differences existed between the high and low SDC1 expression groups regarding disease-free, disease-specific, and overall survival for stage I-III, and only overall survival for stage IV was significantly different. In our study, among the 48 patients, 17 (no recurrence), 13 (1 recurrence), and 18 (10 recurrences) had stage I-III, respectively. Preoperative and postoperative day 7 SDC1 levels for patients with stage I-III were 10.7±2.3 and 9.9±3.1 ng/ml (p=0.40), 11.1±1.7 and 10.1±0.8 ng/ml (p=0.07), and 10.3±2.0 and 9.5±1.4 ng/ml (p=0.15), respectively. In stage II and III, patients were divided into two groups according to differences between preoperative and postoperative SDC1 levels (SDC1pre-pro). SDC1pre-pro ≤0 group significantly prolonged disease-free survival compared with SDC1pre-pro >0 group (p=0.048). Dynamic change in serum SDC1 levels serves as a prognostic biomarker for stage II and III colorectal cancer.

• Publisher: International Institute of Anticancer Research
• Subject: Atherosclerosis / Biomarkers / Biomarkers, Tumor - blood / Body mass index / Cancer / Classification / Colorectal cancer / Colorectal Neoplasms - diagnosis / Colorectal Neoplasms - surgery / Disease / Disease-Free Survival / Enzymes / Extracellular matrix / Glycoproteins / Heart failure / Heparan sulfate / Humans / Metastasis / Microscopy / Patients / Prognosis / Proteoglycans / Surgery / Survival / Survival analysis / Syndecan / Syndecan-1 - blood / Transcriptomics